Last10K.com

China Biologic Products Holdings, Inc. (CBPO) SEC Filing 20-F Annual report for the fiscal year ending Monday, December 31, 2018

China Biologic Products Holdings, Inc.

CIK: 1369868 Ticker: CBPO

View differences made from one year to another to evaluate China Biologic Products Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by China Biologic Products Holdings, Inc..

Continue

Assess how China Biologic Products Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

China Biologic Products Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Comprehensive Income
Accounts Receivable
Accounts Receivable (Schedule Of Accounts Receivable) (Details)
Accounts Receivable (Schedule Of Activity In The Allowance For Doubtful Accounts) (Details)
Accounts Receivable (Tables)
Business Combination
Business Combination (Business Acquisition, Pro Forma Information) (Details)
Business Combination (Narrative) (Details)
Business Combination (Schedule Of Business Acquisitions, By Acquisition) (Details)
Business Combination (Tables)
Capital Withdrawal By Two Former Noncontrolling Interest Shareholdrers Of Guizhou Taibang
Capital Withdrawal By Two Former Noncontrolling Interest Shareholdrers Of Guizhou Taibang (Narrative) (Details)
China Biologic Products Holdings, Inc. (Parent Company)
China Biologic Products Holdings, Inc. (Parent Company) (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details)
Commitments And Contingencies (Narrative) (Details)
Commitments And Contingencies (Tables)
Description Of Business And Significant Concentrations And Risks
Description Of Business And Significant Concentrations And Risks (Narrative) (Details)
Earnings Per Share
Earnings Per Share (Schedule Of Computation Of Basic And Diluted Net Income Per Share (Details)
Earnings Per Share (Tables)
Fair Value Measurements
Fair Value Measurements (Narrative) (Details)
Income Tax
Income Tax (Narrative) (Details)
Income Tax (Tables)
Intangible Assets
Intangible Assets (Narrative) (Details)
Intangible Assets (Schedule Of Amortization Expense For Intangible Assets) (Details)
Intangible Assets (Schedule Of Finite Lived Intangible Assets) (Details)
Intangible Assets (Tables)
Inventories
Inventories (Narrative) (Details)
Inventories (Schedule Of Inventories) (Details)
Inventories (Tables)
Loan Receivable
Loan Receivable (Narrative) (Details)
Options And Nonvested Shares
Options And Nonvested Shares (Narrative) (Details)
Options And Nonvested Shares (Tables)
Other Payables And Accrued Expenses
Other Payables And Accrued Expenses (Narrative) (Details)
Other Payables And Accrued Expenses (Schedule Of Other Payables And Accrued Expenses) (Details)
Other Payables And Accrued Expenses (Tables)
Prepayments And Other Current Assets
Prepayments And Other Current Assets (Narrative) (Details)
Prepayments And Other Current Assets (Schedule Of Activities In Allowance For Doubtful Accounts) (Details)
Prepayments And Other Current Assets (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Narrative) (Details)
Property, Plant And Equipment (Schedule Of Property Plant And Equipment) (Details)
Property, Plant And Equipment (Tables)
Related Party Transactions
Related Party Transactions (Narrative) (Details)
Sales
Sales (Tables)
Schedule Of Condensed Balance Sheets (Details)
Schedule Of Condensed Statements Of Cash Flows (Details)
Schedule Of Condensed Statements Of Comprehensive Income (Details)
Schedule Of Deferred Tax Assets And Liabilities (Details)
Schedule Of Earnings (Losses) Before Income Taxes By Jurisdictions (Details)
Schedule Of Income Tax Expense (Details)
Schedule Of Nonvested Shares Activity (Details)
Schedule Of Reconciliation Of Income Tax Expense (Details)
Schedule Of Sales By Channel Type (Details)
Schedule Of Sales By Product Type (Details)
Schedule Of Stock Options Activity (Details)
Segment Information
Segment Information (Tables)
Segment Information - (Reconciliation Of Assets From Segment To Consolidated) (Details)
Segment Information - (Schedule Of Segment Reporting Information By Segment) (Details)
Statutory Reserves
Statutory Reserves (Narrative) (Details)
Subsequent Events
Subsequent Events (Narrative) (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Narrative) (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Schedule Of Cash And Cash Equivalents) (Details)
Summary Of Significant Accounting Policies (Schedule Of Estimated Useful Lives Of The Assets) (Details)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies(Schedule Of Acquired Finite-Lived Intangible Assets By Major Class) (Details)
Summary Of Valuation Allowance For Deferred Tax Assets (Details)
Ticker: CBPO
CIK: 1369868
Form Type: 20-F Annual Report
Accession Number: 0001144204-19-012555
Submitted to the SEC: Wed Mar 06 2019 4:31:49 PM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Monday, December 31, 2018
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cbpo/0001144204-19-012555.htm